483
Sterling Knight Pharmaceuticals, LLCSterling Knight Pharmaceuticals, LLC – FDA 483, Apr 11, 2019
Record Details
An FDA inspection of Sterling Knight Pharmaceuticals, LLC in Ripley, MS, an own-label distributor of human drug products, revealed significant deficiencies in its quality system. The firm lacks a functional quality control unit responsible for critical tasks like complaint investigations, procedure approval, and contract manufacturer qualification. Additionally, the company failed to follow its own procedures for documenting and investigating consumer complaints.
View Company Profile
ID · 12378dd4-bb70-433e-ab4f-11a6ccf554be
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.